Critical Contrast: Many Bright Ideas Technologies (OTCMKTS:MBGNF) versus Rapid Micro Biosystems (NASDAQ:RPID)

Many Bright Ideas Technologies (OTCMKTS:MBGNF) and Rapid Micro Biosystems (NASDAQ:RPID) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, earnings and dividends.

Institutional and Insider Ownership

52.6% of Rapid Micro Biosystems shares are held by institutional investors. 12.7% of Rapid Micro Biosystems shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Many Bright Ideas Technologies and Rapid Micro Biosystems’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Many Bright Ideas Technologies	N/A	N/A	N/A
Rapid Micro Biosystems	-145.56%	-156.84%	-69.31%

Valuation & Earnings

This table compares Many Bright Ideas Technologies and Rapid Micro Biosystems”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Many Bright Ideas Technologies	N/A	N/A	N/A	N/A	N/A
Rapid Micro Biosystems	$33.59 million	2.23	-$47.12 million	($1.12)	-1.45

Many Bright Ideas Technologies has higher earnings, but lower revenue than Rapid Micro Biosystems.

Analyst Ratings

This is a summary of current recommendations for Many Bright Ideas Technologies and Rapid Micro Biosystems, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Many Bright Ideas Technologies	0	0	0	0	0.00
Rapid Micro Biosystems	1	0	2	0	2.33

Rapid Micro Biosystems has a consensus target price of $6.00, suggesting a potential upside of 269.46%. Given Rapid Micro Biosystems’ stronger consensus rating and higher probable upside, analysts plainly believe Rapid Micro Biosystems is more favorable than Many Bright Ideas Technologies.

Summary

Rapid Micro Biosystems beats Many Bright Ideas Technologies on 6 of the 9 factors compared between the two stocks.

About Many Bright Ideas Technologies

Many Bright Ideas Technologies Inc. does not have significant operations. It was previously engaged in the life science business with a focus on the commercialization of prognostic genomic-based tests for non-small-cell lung cancer. It focuses on the commercialization of technologies in various industrial sectors. The company is headquartered in Vancouver, Canada.

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.